MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by European Institute of Oncology
Sponsor:
Information provided by (Responsible Party):
European Institute of Oncology
ClinicalTrials.gov Identifier:
NCT01264874
First received: December 21, 2010
Last updated: June 17, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2019
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)